FDA Approved: LYRICA CR — Original Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approves LYRICA CR (pregabalin) under an Original Application for an extended-release formulation of pregabalin.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy
• Fibromyalgia
• Generalized Anxiety Disorder
• Partial-onset Seizures
• Postherpetic Neuralgia

Drugs mentioned

• LYRICA CR (PREGABALIN)

Snippet

ORIG AP for LYRICA CR (PREGABALIN)